Log In
BCIQ
Print this Print this
 

Anflu, Split influenza vaccine

  Manage Alerts
Collapse Summary General Information
Company Sinovac Biotech Ltd.
DescriptionSeasonal influenza vaccine
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationInfluenza virus
Indication DetailsVaccinate against influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$683.6M

$683.6M

0


 Deals Details
Get a free BioCentury trial today